Oncolytics Biotech

American biotechnology company

Toronto Stock Exchange · home listing ONCY Nasdaq SEC CIK 1129928
Follow Oncolytics Biotech Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$9.7M +1.8% vs same quarter last year
EPS, diluted −$0.08 +20% vs same quarter last year
Operating cash flow −$6.9M −42.8% vs same quarter last year
Operating income −$9.7M −1.9% vs same quarter last year
Net income by quarter
−$4.7M
−$5.3M
−$9.9M
−$8.9M
−$9.2M
−$9.4M
−$9.7M
Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing